This webinar will discuss the best practices for how molecular diagnostic labs can quickly and effectively launch next-generation sequencing (NGS) hereditary risk genetic testing. The webinar will explore how to implement an effective testing program, particularly market trends and considerations, laboratory setup and validation, data analysis, and reporting, and will share best practices for selecting and implementing a tertiary analysis pipeline for variant interpretation.
Clinical laboratories are rapidly expanding the scope and complexity of their hereditary testing services offered to utilize next-generation sequencing. With this expansion comes a significant number of challenges, including setup, panel design and validation, how to build for optimum turnaround time, and the need for specialized clinical genetic knowledge and overall scalability. A good strategy for selecting and implementing appropriate tertiary analysis tools and setting up a scalable interpretation workflow is critical to the success of a clinical NGS program.